Nanotechnology-Based Cisplatin Intracellular Delivery to Enhance Chemo-Sensitivity of Ovarian Cancer

BACKGROUND: Platinum resistance is a major challenge in the management of ovarian cancer. Even low levels of acquired resistance at the cellular level lead to impaired response to cisplatin. In ovarian cancer intraperitoneal therapy, nanoparticle formulation can improve the cisplatin’s pharmacokinet...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Nanomedicine
Main Authors: Bortot, Barbara, Mongiat, Maurizio, Valencic, Erica, Dal Monego, Simeone, Licastro, Danilo, Crosera, Matteo, Adami, Gianpiero, Rampazzo, Enrico, Ricci, Giuseppe, Romano, Federico, Severini, Giovanni Maria, Biffi, Stefania
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7368240/
https://ncbi.nlm.nih.gov/pubmed/32764921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S247114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados